Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00510510
Status:
COMPLETED
Last Update Posted:
2012-05-21
First Post:
2007-08-01
Brief Title:
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide NVA237 100 or 200 µg Once a Day in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Sponsor:
Novartis
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CNVA237A2206
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None